ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (2): 120-125.DOI: 10.3969/j.issn.1006-298X.2026.02.004

• 论著 • 上一篇    下一篇

血清尿酸动态轨迹与 Ⅲ 期糖尿病肾病患者肾功能下降速率的相关性研究

  

  • 出版日期:2026-04-28 发布日期:2026-04-23

Dynamic uric acid changes are associated with the rate of renal function decline in patients with stage Ⅲ diabetic kidney disease

  • Online:2026-04-28 Published:2026-04-23

摘要: 目的:探究血清尿酸 (SUA) 纵向轨迹与 Ⅲ 期糖尿病肾病患者肾脏损伤进展与预后的关系。方法:纳入 250 例经肾活检诊断为 Ⅲ 期糖尿病肾病的患者,中位随访 4.2 年。患者按随访期间 SUA 经基于组的轨迹模型分为三组,低轨迹组:5.2 (4.6,5.7) mg/dl (n=70); 中轨迹组:6.4 (5.9,7.1) mg/dl (n=125); 高轨迹组:7.7 (6.8,9.1) mg/dL (n=55)。采用广义线性混合效应模型评估 SUA 轨迹组与估算肾小球滤过率 (eGFR) 下降率的关系,肾脏结局定义为 eGFR 下降≥50%、进展至终末期肾病 (ESKD) 或行肾脏替代治疗。采用 Kaplan-Meier 生存分析和 COX 比例风险模型分析 SUA 轨迹分组与肾脏结局之间的关联。结果:随访期间,SUA 每增加 1mg/dL, 在原本 eGFR 年下降率的基础上,低、中、高轨迹组额外变化了 - 0.65%(95% CI-1.25%~-0.03%,P=0.04)、0.45%(95% CI 0.03%~0.87%,P=0.04) 和 - 1.03%(95% CI-1.67%~-0.38%,P<0.01)。共有 192 例 (76.8%) 患者出现了结局事件。在 COX 多变量调整模型中,与低轨迹组相比,中、高轨迹组发生结局事件的风险比分别为 1.291 (95% CI 0.88~1.90,P=0.20)、1.604 (95% CI 1.01~2.54,P=0.043)。结论:本研究发现 SUA 对 eGFR 下降速率的影响在不同轨迹组间呈 U 型分布,且长期持续高 SUA 是进展至肾脏结局的独立危险因素。

关键词: Ⅲ 期糖尿病肾病, 血清尿酸, 轨迹分析, 肾功能下降, 肾小球滤过率

Abstract: Objective:To investigate the relationship between longitudinal serum uric acid (SUA) trajectories and the progression and prognosis of kidney injury in patients with stage Ⅲ diabetic kidney disease (DKD). Methods:This study enrolled 250 patients with biopsy-proven stage Ⅲ DKD,with a median follow-up of 4.2 years.Group-based trajectory modeling applied to serial SUA measurements was used to identify three distinct trajectory groups:a low-trajectory group [5.2 (4.6,5.7) mg/dl,n=70], a moderate-trajetory group [6.4 (5.9,7.1) mg/dl,n=125], and a high-trajectory group [7.7 (6.8,9.1) mg/dL,n=55]. The association between SUA trajectory groups and the rate of estimated glomerular filtration rate (eGFR) decline was assessed using generalized linear mixed-effects models.The composite kidney outcome was defined as a≥50% decline in eGFR,progression to end-stage kidney disease (ESKD),or initiation of kidney replacement therapy.Kaplan-Meier survival analysis and Cox proportional hazards models were employed to analyze the association between SUA trajectory groups and the kidney outcome. Results:During follow-up,for each 1mg/dL increase in SUA,on top of the annual rate of eGFR decline,the low,moderate,and high trajectory groups showed additional changes of -0.65%(95% CI-1.25%~-0.03%,P=0.04),0.45%(95% CI 0.03%~0.87%,P=0.04),and -1.03%(95% CI-1.67%~-0.38%,P<0.01), respectively. A total of 192 patients (76.8%) experienced the composite kidney outcome.In the multivariable-adjusted Cox model,compared to the low-trajectory group,the hazard ratios (HRs) for the moderate- and high-trajectory groups were 1.291 (95% CI 0.88~1.90,P=0.20) and 1.604 (95% CI 1.01~2.54,P=0.043).Conclusion: This study found that the effect of SUA on the rate of eGFR decline exhibited a U-shaped distribution across different trajectory groups.Furthermore,maintaining a high SUA level over the long term is an independent risk factor for progression to the composite kidney outcome.

Key words: stage Ⅲ diabetic kidney disease,serum uric acid,trajectory analysis,renal function decline,estimated glomerular filtration rate